SEHK:2342
SEHK:2342Communications

Comba Telecom (SEHK:2342): Valuation Insights as Board Welcomes Dr. Tan Khee Giap

Comba Telecom Systems Holdings (SEHK:2342) is making headlines after the board announced a key change in its independent director lineup. Ms. Wong Lok Lam is stepping down. Dr. Tan Khee Giap will step in, bringing extensive cross-sector expertise. See our latest analysis for Comba Telecom Systems Holdings. After a remarkable surge earlier this year, Comba Telecom’s share price has recently cooled. The stock posted a 1-day gain of 2.46% but experienced a 30-day drop of 9.91%. Still, the...
SEHK:1357
SEHK:1357Interactive Media and Services

Will Meitu (SEHK:1357) Leverage Its Crypto Legacy for a New Chapter in Digital Asset Strategy?

Earlier this week, Huobi founder Li Lin, alongside leading Asian crypto investors including backers with ties to Meitu, announced the raising of US$1 billion to establish an Ethereum-focused digital asset trust structured through a Nasdaq-listed shell company. The initiative's scale and participation from well-known digital asset firms have brought renewed attention to Meitu, given its prior crypto engagement and the sector’s growing momentum in institutional Ethereum exposure. We'll explore...
SEHK:1717
SEHK:1717Food

Asian Small Caps With Insider Buying That Are Undervalued

Amidst the backdrop of global market volatility and evolving economic conditions, Asian small-cap stocks are garnering attention, particularly as investors navigate the complexities of U.S.-China trade tensions and fluctuating interest rates. In this environment, identifying stocks that demonstrate strong fundamentals and insider buying can be key indicators of potential value, offering intriguing opportunities for those looking to explore the Asian small-cap landscape.
SEHK:9857
SEHK:9857Entertainment

Asian Market Insights: Wealthink AI-Innovation Capital Among 3 Promising Penny Stocks

As global markets navigate a period of economic uncertainty, with trade tensions and monetary policy shifts making headlines, investors are increasingly seeking opportunities in diverse sectors. Penny stocks, often associated with smaller or newer companies, present intriguing possibilities for those looking to explore beyond the mainstream market. Despite being considered an outdated term by some, these stocks continue to offer potential growth at accessible price points when backed by solid...
SEHK:1913
SEHK:1913Luxury

Asian Dividend Stocks To Consider For Your Portfolio

As global markets navigate a landscape marked by U.S.-China trade tensions and monetary policy shifts, investors are increasingly looking toward Asia for opportunities in dividend stocks. In such a dynamic environment, a good dividend stock is typically characterized by its ability to maintain stable payouts and demonstrate resilience amid economic fluctuations.
SEHK:1177
SEHK:1177Pharmaceuticals

Does Sino Biopharm Offer Value After Jumping 135% and Expanding in Asia in 2025?

If you have been watching Sino Biopharmaceutical, you are probably wondering what to make of this stock after such a rollercoaster ride. The past year has brought a surge that few predicted, with the stock up an eye-catching 135.6% since the start of the year and 95.3% over the last twelve months. Even looking back three years, the company has notched an impressive 83.5% gain. Yet, this momentum hit a speed bump recently, with prices dropping 6.7% in the last week and falling 13.2% over the...
SEHK:1357
SEHK:1357Interactive Media and Services

Meitu (SEHK:1357): Assessing Valuation After Recent 5% Share Price Dip

Meitu (SEHK:1357) shares have seen a dip, with the stock slipping over 5% in recent trading. Investors are watching closely as the company navigates shifting market sentiment and re-evaluates its business strategies. See our latest analysis for Meitu. Meitu's recent slide comes after a year marked by dramatic momentum shifts, with the share price posting an impressive year-to-date return of 185.76%. Short-term volatility aside, long-term investors have enjoyed a stellar one-year total...
SEHK:2096
SEHK:2096Pharmaceuticals

Evaluating Simcere Pharmaceutical Group (SEHK:2096) Valuation After First U.S. Patient Dosed in Oncology Trial

Simcere Pharmaceutical Group (SEHK:2096) has advanced its oncology program with the first U.S. patient dosed in the Phase 1 trial of SIM0505 for advanced solid tumors. This development expands the clinical reach beyond China and draws investor attention to ongoing trial progress. See our latest analysis for Simcere Pharmaceutical Group. Simcere’s recent momentum is hard to miss, with the stock’s 91.5% year-to-date share price return fueled by progress in its expanding oncology pipeline...
SEHK:26
SEHK:26Real Estate

China Motor Bus (SEHK:26) Losses Escalate 45% Per Year, Undermining Premium Valuation Narrative

China Motor Bus Company (SEHK:26) is currently in the red, with net losses growing at a rate of 45% per year over the past five years. Despite ongoing losses, the company’s price-to-sales ratio comes in at 16x, far above the Hong Kong Real Estate industry average of 0.7x and the peer average of 2.7x. With shares last changing hands at HK$59, investors are paying a steep premium compared to the discounted cash flow fair value estimate of HK$41.92, and there are no signs of accelerating profit...
SEHK:2670
SEHK:2670Machinery

Beijing Yunji Technology (SEHK:2670): Evaluating Valuation After Latest Double-Digit Share Price Drop

Beijing Yunji Technology (SEHK:2670) shares fell over 11% as investors took notice of the recent drop. The decline has caught attention, particularly in light of the company's year-to-date performance and current trading levels. See our latest analysis for Beijing Yunji Technology. Beijing Yunji Technology’s recent 1-day share price return of -11.2% gives investors pause, especially as this drop mirrors its year-to-date share price return. This suggests momentum has turned negative after...
SEHK:9660
SEHK:9660Software

Assessing Horizon Robotics After 22% Drop and AI Hardware Market Surge in 2025

Thinking about what to do with Horizon Robotics stock at this crossroad? You’re not alone. The company’s share price has been on a wild ride lately, and for anyone with skin in the game, those big swings can make decisions anything but straightforward. In the past week alone, Horizon Robotics dropped by 11.1%, and over the last 30 days, the stock slipped a notable 22.8%. Yet, if you take a step back, you’ll see the year-to-date return standing strong at 129.3%. That kind of run-up usually...